ArticleAnnals of the rheumatic diseases2022
Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'.
Article in Annals of the rheumatic diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Infectious Complications of Pulmonary Sarcoidosis.Journal of clinical medicine · 2024Review
- Outcomes in patients with sarcoidosis and COVID-19.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023Article
- COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.Scientific reports · 2023Article
- A review of the presentation and outcome of sarcoidosis in coronavirus disease 2019.Journal of clinical and translational research · 2021Review
- Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study.Respiratory medicine · 2021Article
- Article
- Article
- Treatment of COVID-19 in Patients With Sarcoidosis.Frontiers in medicine · 2021Review
- COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
33004334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.